GlassScriptPhysician profile
Stanislav Goykhman
NPI 1740488402
$278,450.21
in general payments reported to CMS, 2019-2025
74 companies · $57K in 2025
The $57K reported for 2025 was more than what 96% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $55K · 2020: $46K · 2021: $21K · 2022: $18K · 2023: $32K · 2024: $49K · 2025: $57K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $75K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $37K · Food and Beverage: $15K · Travel and Lodging: $10K · Consulting Fee: $580 · Education: $197.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75,231.25 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $37,343.00 |
| Food and Beverage | $14,561.57 |
| Travel and Lodging | $10,241.72 |
| Consulting Fee | $580.00 |
| Education | $197.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $79,472.87 | 2019-2025 | Jardiance, Tradjenta, Synjardy |
| Lilly USA, LLC | $71,458.20 | 2019-2025 | Zepbound, Jardiance, Mounjaro |
| Dexcom, INC. | $42,983.31 | 2021-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $42,285.61 | 2019-2025 | Farxiga, Lokelma |
| Amarin Pharma, INC. | $21,183.37 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $4,512.19 | 2019-2023 | Steglatro |
| Novo Nordisk INC | $3,968.91 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Sanofi-Aventis U.S. LLC | $1,621.69 | 2019-2025 | |
| Medtronic Minimed, INC. | $1,417.27 | 2019-2020 | |
| Corcept Therapeutics | $1,040.42 | 2019-2025 | Korlym |
| Amgen INC. | $935.39 | 2019-2025 | Tepezza, Repatha, Prolia |
| Novo Nordisk As | $580.00 | 2023 | |
| Insulet Corporation | $573.89 | 2019-2025 | Omnipod |
| Tandem Diabetes Care, INC. | $570.82 | 2020-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Mannkind Corporation | $564.11 | 2019-2025 |
Show all 74 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $526.91 | 2021-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
| Amneal Pharmaceuticals LLC | $518.23 | 2020-2025 | Unithroid |
| Abbvie INC. | $393.61 | 2019-2025 | |
| Abbott Laboratories | $350.22 | 2021-2025 | Freestyle Libre 3 |
| Xeris Pharmaceuticals, INC. | $308.68 | 2020-2025 | Gvoke Hypopen, Recorlev |
| Bayer Healthcare Pharmaceuticals INC. | $305.14 | 2023-2025 | |
| Cequr Corporation | $279.15 | 2021-2025 | Cequr Simplicity |
| Antares Pharma, INC. | $204.04 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Ascendis Pharma Endocrinology INC | $182.98 | 2025 | Yorvipath |
| Pfizer INC. | $137.12 | 2021-2025 | |
| Radius Health, INC. | $115.77 | 2019-2025 | Tymlos |
| Janssen Pharmaceuticals, INC | $95.06 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $91.86 | 2019-2025 | Relistor, Cycloset |
| Genzyme Corporation | $85.89 | 2020-2022 | |
| Neurocrine Biosciences, INC. | $81.17 | 2024-2025 | |
| Madrigal Pharmaceuticals | $79.21 | 2025 | Rezdiffra |
| Novartis Pharmaceuticals Corporation | $76.36 | 2022-2025 | |
| Beta Bionics, INC. | $70.25 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Amphastar Pharmaceuticals, INC. | $68.86 | 2023-2025 | Baqsimi |
| Azurity Pharmaceuticals, INC. | $63.97 | 2023-2025 | Azmiro, Adthyza, Horizant |
| Tolmar, INC. | $61.78 | 2024-2025 | Jatenzo |
| Alexion Pharmaceuticals, INC. | $58.69 | 2020-2024 | Strensiq |
| Topcon Healthcare Solutions, INC. | $58.06 | 2019 | |
| Esperion Therapeutics, INC. | $57.77 | 2021-2024 | Nexletol |
| Vistapharm, INC. | $55.87 | 2021 | |
| Chiesi USA, INC. | $52.66 | 2025 | Mycapssa |
| Amryt Pharma Holdings LTD | $50.78 | 2022-2023 | Mycapssa |
| Recordati_rare_diseases_inc. | $47.18 | 2020-2024 | Signifor Lar, Isturisa |
| Zealand Pharma US, INC. | $44.02 | 2021-2022 | |
| Embecta Corp. | $43.95 | 2023-2024 | Bd Nano 2nd Gen Pen Needle |
| Clarus Therapeutics INC. | $43.60 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $42.63 | 2022-2025 | Zoryve |
| Ibsa Pharma INC. | $39.62 | 2022-2023 | Tirosint, Licart |
| Eisai INC. | $35.78 | 2019 | |
| Halozyme INC | $35.55 | 2023 | |
| Currax Pharmaceuticals LLC | $32.28 | 2024-2025 | Contrave |
| Horizon Therapeutics Plc | $31.02 | 2023 | Tepezza |
| Verity Pharmaceuticals INC. | $30.98 | 2024 | Tlando |
| Vivus LLC | $30.72 | 2020 | |
| Shire North American Group INC | $27.87 | 2019 | |
| Rhythm Pharmaceuticals, INC. | $27.73 | 2022 | |
| Becton, Dickinson and Company | $26.75 | 2020-2022 | |
| Valeritas, INC. | $26.68 | 2019 | |
| Cmp Pharma, INC. | $26.64 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $26.31 | 2019 | |
| Echosens North America, INC. | $22.88 | 2024 | Fibroscan |
| Ultragenyx Pharmaceutical INC. | $19.56 | 2023 | |
| Ascensia Diabetes Care US INC. | $19.05 | 2025 | |
| Smith+Nephew, INC. | $18.75 | 2025 | Collagenase Santyl |
| Averitas Pharma INC. | $18.00 | 2025 | Qutenza |
| Axsome Therapeutics, INC. | $16.11 | 2023 | Sunosi |
| Hikma Pharmaceuticals USA | $15.63 | 2023 | Ryaltris |
| Lundbeck LLC | $15.51 | 2023 | Rexulti |
| Intuity Medical INC | $15.44 | 2022 | |
| Glaxosmithkline, LLC. | $15.13 | 2025 | Arexvy, Shingrix |
| Sanofi Pasteur INC. | $15.00 | 2023 | |
| Lupin INC. | $14.42 | 2019 | |
| Lifescan, INC. | $14.42 | 2019 | |
| Gilead Sciences, INC. | $12.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanislav Goykhman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.